Dan Sperling

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▷ joint publications with Robert Toth

> Home > Persons > Dan Sperling

Publications

2014
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/ijon/ViswanathTRSLFM14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/ijon/ViswanathTRSLFM14
Satish Viswanath, Robert Toth, Mirabela Rusu, Dan Sperling, Herbert Lepor, Jurgen J. Fütterer, Anant Madabhushi:
Identifying quantitative in vivo multi-parametric MRI features for treatment related changes after laser interstitial thermal therapy of prostate cancer. Neurocomputing 144: 13-23 (2014)
2013
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/cviu/TothRGSM13
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cviu/TothRGSM13
Robert Toth, Justin Ribault, John Gentile, Dan Sperling, Anant Madabhushi:
Simultaneous segmentation of prostatic zones using Active Appearance Models with multiple coupled levelsets. Comput. Vis. Image Underst. 117(9): 1051-1060 (2013)
[c1]
- view
  authority control:
- export record
  dblp key:
  - conf/miigp/ViswanathTRSLFM13
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/miigp/ViswanathTRSLFM13
Satish Viswanath, Robert Toth, Mirabela Rusu, Dan Sperling, Herbert Lepor, Jurgen J. Fütterer, Anant Madabhushi:
Quantitative evaluation of treatment related changes on multi-parametric MRI after laser interstitial thermal therapy of prostate cancer. Medical Imaging: Image-Guided Procedures 2013: 86711F

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.